Quinazoline antifolates as inhibitors of growth, dihydrofolate reductase, and thymidylate synthetase of mouse neuroblastoma cells in culture

S. C. Carlin, R. N. Rosenberg, L. VandeVenter, M. Friedkin

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Correlations between inhibition of growth and of enzyme activity by several quinazoline analogues of folic acid have been made with two lines of C1300 mouse neuroblastoma cells, one sensitive and one resistant to quinazoline analogues. The quinazoline analogues studied fell into two classes: 2,4 diamino and 2 amino 4 hydroxy derivatives. The 2,4 diamino quinazoline analogues DAQ (N [p [[(2,4 diamino 6 quinazolinyl)methyl]methylamino]benzoyl] L glutamic acid) and methasquin (N [p [(2,4 diamino 5 methylquinazolinyl)methylamino]benzoyl] L aspartic acid) effectively inhibited both cell growth and dihydrofolate reductase activity, whereas the 2 amino 4 hydroxyquinazoline analogue AHQ (N [p [[(2 amino 4 hydroxy 6 quinazolinyl)methyl]methylamino]benzoyl] L glutamic acid) was less potent. Nevertheless, AHQ was more inhibitory toward thymidylate synthetase than DAQ. With the 2,4 diaminoquinazoline analogues there was a good correlation between inhibition of growth and dihydrofolate reductase, but with AHQ growth inhibition seemed to depend upon the inhibition of both dihydrofolate reductase and thymidylate synthetase. Sensitive cells could be completely protected against the toxic effects of AHQ by either leukovorin or thymidine; the concentration of leukovorin (0.56 μM) necessary to provide 50% protection against a lethal dose of AHQ (30 μM) was 38 times less than the amount of thymidine (21 μM) required for 50% protection. Because of its unique potency toward thymidylate synthetase, AHQ may be useful in the chemotherapy of neuroblastoma.

Original languageEnglish (US)
Pages (from-to)194-203
Number of pages10
JournalMolecular Pharmacology
Volume10
Issue number2
StatePublished - 1974

Fingerprint

dihydrofolate synthetase
Quinazolines
Folic Acid Antagonists
Thymidylate Synthase
Growth Inhibitors
Neuroblastoma
Tetrahydrofolate Dehydrogenase
Cell Culture Techniques
Leucovorin
Growth
Thymidine
Glutamic Acid
Poisons
Folic Acid
Aspartic Acid
Drug Therapy
Enzymes

ASJC Scopus subject areas

  • Pharmacology

Cite this

Quinazoline antifolates as inhibitors of growth, dihydrofolate reductase, and thymidylate synthetase of mouse neuroblastoma cells in culture. / Carlin, S. C.; Rosenberg, R. N.; VandeVenter, L.; Friedkin, M.

In: Molecular Pharmacology, Vol. 10, No. 2, 1974, p. 194-203.

Research output: Contribution to journalArticle

@article{ea4b6abff6734cbb9f1266d9a420f5cc,
title = "Quinazoline antifolates as inhibitors of growth, dihydrofolate reductase, and thymidylate synthetase of mouse neuroblastoma cells in culture",
abstract = "Correlations between inhibition of growth and of enzyme activity by several quinazoline analogues of folic acid have been made with two lines of C1300 mouse neuroblastoma cells, one sensitive and one resistant to quinazoline analogues. The quinazoline analogues studied fell into two classes: 2,4 diamino and 2 amino 4 hydroxy derivatives. The 2,4 diamino quinazoline analogues DAQ (N [p [[(2,4 diamino 6 quinazolinyl)methyl]methylamino]benzoyl] L glutamic acid) and methasquin (N [p [(2,4 diamino 5 methylquinazolinyl)methylamino]benzoyl] L aspartic acid) effectively inhibited both cell growth and dihydrofolate reductase activity, whereas the 2 amino 4 hydroxyquinazoline analogue AHQ (N [p [[(2 amino 4 hydroxy 6 quinazolinyl)methyl]methylamino]benzoyl] L glutamic acid) was less potent. Nevertheless, AHQ was more inhibitory toward thymidylate synthetase than DAQ. With the 2,4 diaminoquinazoline analogues there was a good correlation between inhibition of growth and dihydrofolate reductase, but with AHQ growth inhibition seemed to depend upon the inhibition of both dihydrofolate reductase and thymidylate synthetase. Sensitive cells could be completely protected against the toxic effects of AHQ by either leukovorin or thymidine; the concentration of leukovorin (0.56 μM) necessary to provide 50{\%} protection against a lethal dose of AHQ (30 μM) was 38 times less than the amount of thymidine (21 μM) required for 50{\%} protection. Because of its unique potency toward thymidylate synthetase, AHQ may be useful in the chemotherapy of neuroblastoma.",
author = "Carlin, {S. C.} and Rosenberg, {R. N.} and L. VandeVenter and M. Friedkin",
year = "1974",
language = "English (US)",
volume = "10",
pages = "194--203",
journal = "Molecular Pharmacology",
issn = "0026-895X",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "2",

}

TY - JOUR

T1 - Quinazoline antifolates as inhibitors of growth, dihydrofolate reductase, and thymidylate synthetase of mouse neuroblastoma cells in culture

AU - Carlin, S. C.

AU - Rosenberg, R. N.

AU - VandeVenter, L.

AU - Friedkin, M.

PY - 1974

Y1 - 1974

N2 - Correlations between inhibition of growth and of enzyme activity by several quinazoline analogues of folic acid have been made with two lines of C1300 mouse neuroblastoma cells, one sensitive and one resistant to quinazoline analogues. The quinazoline analogues studied fell into two classes: 2,4 diamino and 2 amino 4 hydroxy derivatives. The 2,4 diamino quinazoline analogues DAQ (N [p [[(2,4 diamino 6 quinazolinyl)methyl]methylamino]benzoyl] L glutamic acid) and methasquin (N [p [(2,4 diamino 5 methylquinazolinyl)methylamino]benzoyl] L aspartic acid) effectively inhibited both cell growth and dihydrofolate reductase activity, whereas the 2 amino 4 hydroxyquinazoline analogue AHQ (N [p [[(2 amino 4 hydroxy 6 quinazolinyl)methyl]methylamino]benzoyl] L glutamic acid) was less potent. Nevertheless, AHQ was more inhibitory toward thymidylate synthetase than DAQ. With the 2,4 diaminoquinazoline analogues there was a good correlation between inhibition of growth and dihydrofolate reductase, but with AHQ growth inhibition seemed to depend upon the inhibition of both dihydrofolate reductase and thymidylate synthetase. Sensitive cells could be completely protected against the toxic effects of AHQ by either leukovorin or thymidine; the concentration of leukovorin (0.56 μM) necessary to provide 50% protection against a lethal dose of AHQ (30 μM) was 38 times less than the amount of thymidine (21 μM) required for 50% protection. Because of its unique potency toward thymidylate synthetase, AHQ may be useful in the chemotherapy of neuroblastoma.

AB - Correlations between inhibition of growth and of enzyme activity by several quinazoline analogues of folic acid have been made with two lines of C1300 mouse neuroblastoma cells, one sensitive and one resistant to quinazoline analogues. The quinazoline analogues studied fell into two classes: 2,4 diamino and 2 amino 4 hydroxy derivatives. The 2,4 diamino quinazoline analogues DAQ (N [p [[(2,4 diamino 6 quinazolinyl)methyl]methylamino]benzoyl] L glutamic acid) and methasquin (N [p [(2,4 diamino 5 methylquinazolinyl)methylamino]benzoyl] L aspartic acid) effectively inhibited both cell growth and dihydrofolate reductase activity, whereas the 2 amino 4 hydroxyquinazoline analogue AHQ (N [p [[(2 amino 4 hydroxy 6 quinazolinyl)methyl]methylamino]benzoyl] L glutamic acid) was less potent. Nevertheless, AHQ was more inhibitory toward thymidylate synthetase than DAQ. With the 2,4 diaminoquinazoline analogues there was a good correlation between inhibition of growth and dihydrofolate reductase, but with AHQ growth inhibition seemed to depend upon the inhibition of both dihydrofolate reductase and thymidylate synthetase. Sensitive cells could be completely protected against the toxic effects of AHQ by either leukovorin or thymidine; the concentration of leukovorin (0.56 μM) necessary to provide 50% protection against a lethal dose of AHQ (30 μM) was 38 times less than the amount of thymidine (21 μM) required for 50% protection. Because of its unique potency toward thymidylate synthetase, AHQ may be useful in the chemotherapy of neuroblastoma.

UR - http://www.scopus.com/inward/record.url?scp=0015994103&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0015994103&partnerID=8YFLogxK

M3 - Article

VL - 10

SP - 194

EP - 203

JO - Molecular Pharmacology

JF - Molecular Pharmacology

SN - 0026-895X

IS - 2

ER -